| Literature DB >> 34189496 |
Fumiaki Yokoi1, Mai Tu Dang2, Lin Zhang1,3, Kelly M Dexter1, Iakov Efimenko1, Shiv Krishnaswamy1, Matthew Villanueva1, Carly I Misztal1, Malinda Gerard1, Patrick Lynch1, Yuqing Li1.
Abstract
DYT-TOR1A or DYT1 early-onset generalized dystonia is an inherited movement disorder characterized by sustained muscle contractions causing twisting, repetitive movements, or abnormal postures. The majority of the DYT1 dystonia patients have a trinucleotide GAG deletion in DYT1/TOR1A. Trihexyphenidyl (THP), an antagonist for excitatory muscarinic acetylcholine receptor M1, is commonly used to treat dystonia. Dyt1 heterozygous ΔGAG knock-in (KI) mice, which have the corresponding mutation, exhibit impaired motor-skill transfer. Here, the effect of THP injection during the treadmill training period on the motor-skill transfer to the accelerated rotarod performance was examined. THP treatment reversed the motor-skill transfer impairment in Dyt1 KI mice. Immunohistochemistry showed that Dyt1 KI mice had a significant reduction of the dorsolateral striatal cholinergic interneurons. In contrast, Western blot analysis showed no significant alteration in the expression levels of the striatal enzymes and transporters involved in the acetylcholine metabolism. The results suggest a functional alteration of the cholinergic system underlying the impairment of motor-skill transfer and the pathogenesis of DYT1 dystonia. Training with THP in a motor task may improve another motor skill performance in DYT1 dystonia.Entities:
Keywords: ACh, acetylcholine; AChE, acetylcholinesterase; BSA, bovine serum albumin; CI, confidence interval; ChAT, choline acetyltransferase; ChI, cholinergic interneuron; ChT, choline transporter; Cholinergic interneuron; DAB, 3,3′-diaminobenzidine; DF, degrees of freedom; Dystonia; Dyt1 KI mice, Dyt1 ΔGAG heterozygous knock-in mice; GAPDH, Glyceraldehyde-3-phosphate dehydrogenase; KO, knockout; LTD, long-term depression; Motor learning; PB, phosphate buffer; PBS, phosphate-buffered saline; PET, positron emission tomography; Rotarod; THP, trihexyphenidyl; TOR1A; TorsinA; TrkA, tropomyosin receptor kinase A; VAChT, vesicular acetylcholine transporter; WT, wild-type; n.s., not significant
Year: 2021 PMID: 34189496 PMCID: PMC8215213 DOI: 10.1016/j.ibneur.2021.05.003
Source DB: PubMed Journal: IBRO Neurosci Rep ISSN: 2667-2421
Fig. 1Motor-skill transfer from treadmill training to accelerated rotarod test. (A) The time scheme of saline- or THP-injection (the arrows show injection days), resting (light blue bars) on the static treadmill belt, treadmill training (light green), and accelerated rotarod test (red bars). The dark blue bars indicate no behavioral experiments. (B) Motor-skill transfer in saline-injected mice. WT mice showed improved performance on the accelerated rotarod after treadmill training. In contrast, Dyt1 KI mice failed to show motor-skill transfer as previously reported without saline injection. (C). Motor-skill transfer with THP injection. Both WT and Dyt1 KI mice showed increased latency to fall after treadmill training with THP injections, suggesting no side effect in WT and recovery from the impaired motor-skill transfer in Dyt1 KI mice by THP, respectively. The bar graphs represent means ± standard errors of latency to fall. *p < 0.05; ***p < 0.001; n.s.: not significant.
Fig. 2Immunohistochemistry of the striatal ChIs. Representative images of the ChAT-positive cells in WT (A) and Dyt1 KI (B) mice. Scale bars represent 50 µm. (C) There was a significant reduction of the ChI density in the dorsolateral (DL) striatum. The bar graphs indicate means ± standard errors of the ChI densities (ChAT-positive cell numbers/mm2). +p < 0.1; *p < 0.05; n.s.: not significant.
Fig. 3Western blot analysis of the striatal tissues. The representative images for ChAT (A), VAChT (B), ChT (double bands at 75 kDa and a single band at 63 kDa; C), AChE (D), and TrkA (E) are shown. (F) The quantified signal of each protein was normalized with those of the loading control proteins, i.e., β-tubulin or GAPDH. There was no significant difference in the ACh metabolic enzymes, transporters, or another ChI marker protein (TrkA) between WT and Dyt1 KI mice. The bar graphs indicate means ± standard errors of the normalized signals. n.s.: not significant.